← Back to OBSOLETE: Tuberculous meningitis

OBSOLETE: Tuberculous meningitis

Advocacy intelligence hub — real-time data for patient organizations

View full disease page →Search clinical trials →
Download CSV

At a Glance

Live from database

Regulatory Watchboard

4 events
Feb 2026B-PaLMZ for TB Meningitis

University of Minnesota — PHASE2

TrialNOT YET RECRUITING
Mar 2024Intensified Short Course Regimen for TBM in Adults

Indian Council of Medical Research — PHASE3

TrialNOT YET RECRUITING
Dec 2023Trial of a Six-Month Regimen of High-Dose Rifampicin, High-Dose Isoniazid, Linezolid, and Pyrazinamide Versus a Standard Nine-Month Regimen for the Treatment of Adults and Adolescents With Tuberculous Meningitis

National Institute of Allergy and Infectious Diseases (NIAID) — PHASE2

TrialRECRUITING
Apr 2023Tnf Inhibitors to Reduce Mortality in HIV-1 Infected PAtients With Tuberculosis meNIngitis

ANRS, Emerging Infectious Diseases — PHASE2

TrialRECRUITING

Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Financial Assistance

FINANCIAL LANDSCAPE SUMMARY

0

Total programs

No financial assistance programs currently listed for OBSOLETE: Tuberculous meningitis.
Check the disease page for updates →

Clinical Trial Landscape

2 active trials
2Phase 2
2Total recruiting
Search clinical trials for OBSOLETE: Tuberculous meningitis

Recent News & Research

No recent news articles indexed yet for OBSOLETE: Tuberculous meningitis.
Search PubMed for OBSOLETE: Tuberculous meningitis

Browse all OBSOLETE: Tuberculous meningitis news →

Specialist Network

No specialists currently listed for OBSOLETE: Tuberculous meningitis.

View all OBSOLETE: Tuberculous meningitis specialists →

Quick Actions